Maynard Um
-
-
-
-
-
-
-
vTv Therapeutics (VTVT) Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
-
-
-
-
-
-
-
vTv Therapeutics (VTVT) Misses Q2 EPS by 81c
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

